WallStSmart

Braskem SA Class A (BAK)vsLinde plc Ordinary Shares (LIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 93% more annual revenue ($66.75B vs $34.65B). LIN leads profitability with a 20.4% profit margin vs -13.7%. BAK appears more attractively valued with a PEG of 1.46. LIN earns a higher WallStSmart Score of 62/100 (C+).

BAK

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

LIN

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

LINSignificantly Overvalued (-70.2%)

Margin of Safety

-70.2%

Fair Value

$298.47

Current Price

$507.90

$209.43 premium

UndervaluedFair: $298.47Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK2 strengths · Avg: 10.0/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-4.3010/10

Conservative balance sheet, low leverage

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$229.28B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.5%8/10

Strong operational efficiency at 28.5%

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$1.66B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Revenue GrowthGrowth
-20.4%2/10

Revenue declined 20.4%

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.5%.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

BAK profiles as a turnaround stock while LIN is a mature play — different risk/reward profiles.

LIN carries more volatility with a beta of 0.74 — expect wider price swings.

LIN is growing revenue faster at 8.2% — sustainability is the question.

LIN generates stronger free cash flow (898M), providing more financial flexibility.

Bottom Line

LIN scores higher overall (62/100 vs 38/100), backed by strong 20.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Want to dig deeper into these stocks?